Topic: Roy Herbst
Don't fill in this field IdeaFeed Home Tags Subscribe (RSS) Tweet . What's the Latest Development?. . The F.D.A. has brought new health warnings to...
In advanced non-small-cell lung cancer patients with progression after first-line therapy, the addition of vandetanib to a standard chemotherapy regimen of docetaxel may significantly improve progression-free survival and response rates compared to standard chemotherapy alone, according to a study published online June ...
Advances in genetics and biomarker identification and testing are finally bearing fruit in the battle against lung cancer, a new set of studies suggests.. Until now, lung cancer has lagged behind other malignancies when it comes to identifying molecular features of the ...
1/13/2010 Print E-mail Advances in genetics and biomarker identification and testing are finally bearing fruit in the battle against lung cancer, a new set of studies suggests.. Until now, lung cancer has lagged behind other malignancies when it comes to ...
That's the conclusion of studies presented Saturday at the annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Fla.. In data presented at an ASCO news conference Saturday, researchers found that the drug Alimta (pemetrexed) prolonged survival by ...
For so long, many people feared cancer more than other illnesses because the diagnosis often meant death. "We can turn this disease into a chronic disorder--something you've got, but you can go to work, have a life, and be happy," says ...
Erbitux extends the life of lung cancer patients - a little. Those who received chemotherapy plus Erbitux survived a median of 11.3 months, compared with 10.1 months for chemotherapy alone.. Many of those patients may now receive Erbitux, - especially if the ...
Erbitux extends the life of lung cancer patients - a little. Those who received chemotherapy plus Erbitux survived a median of 11.3 months, compared with 10.1 months for chemotherapy alone.. Many of those patients may now receive Erbitux, - especially if the ...
A new gene test can predict how people with lung cancer will fare, say researchers, allowing aggressive chemotherapy to be targeted to only those who need it. The process involves extracting messenger RNA from cells and translating this into DNA fragments that ...
Video Gallery
-
Personalized Therapy for Advanced NSCLC
Roy S Herbst, MD, PhD Dr. Roy Herbst discusses the ...2011-10-25 -
Dream Team looks to circulating tumor ...
Tumor genetics must be analyzed to personalize lung cancer treatment ...2010-09-10 -
Update From World Conference on Lung ...
Dr. Roy S. Herbst highlighted the FLEX post hoc analysis ...2011-07-12
